Radiology Doctors in Rice Lake, WI Accepting Medicare

8 Radiology doctors found. Showing 1 - 8

Thomas Michael Pelant, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1024 N Main St, Rice Lake, WI 54868 Phone: 715-234-8151    Fax: 715-234-9750

Robert D Lefsrud, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1024 N Main St, Rice Lake, WI 54868 Phone: 715-234-8151    Fax: 715-234-9750

Steven F Krah, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1700 W Stout St, Rice Lake, WI 54868 Phone: 715-236-8100

Natasha Eshbaugh, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1024 N Main St, Rice Lake, WI 54868 Phone: 715-234-8151    Fax: 715-234-9750

Richard W Swanson, M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 1024 N Main St, Rice Lake, WI 54868 Phone: 715-234-8151    Fax: 715-234-7950

Gary A Johnson, M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 1024 N Main St, Rice Lake, WI 54868 Phone: 715-234-8151    Fax: 715-234-9750

Fabio Emiliano Valenzuela Sosa, MD Radiology - Radiation Oncology Medicare: Not Enrolled in Medicare Practice Location: 1700 W Stout St, Rice Lake, WI 54868 Phone: 715-236-8100

John A Terrell, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1024 North Main Street, Rice Lake, WI 54868 Phone: 715-234-8151    Fax: 715-234-9750

News Archive

Affiliate of Sun Capital acquires CornerStone

Sun Capital Partners, Inc., a leading private investment firm specializing in leveraged buyouts and investments in market-leading companies, today announced that an affiliate has acquired CornerStone Research & Development, Inc., a leading global contract manufacturer of top-branded vitamins and dietary supplements, from Mitsui & Co. (U.S.A.), Inc.

FDA new approvals, antibiotic and neurological drugs

Two new drugs have gained approval from the US Food and Drug Administration (FDA) – one is an antibiotic from Forest Labs and the other a first-time treatment for a neurological disorder developed by Avanir Pharmaceuticals. Another waiting for approval is Biodel's fast-acting insulin Linjeta. On the other hand seven new drugs got rejected including a diabetes drug from Amylin Pharmaceuticals and weight-loss drugs from Arena Pharmaceuticals and Vivus, respectively.

Yale researchers develop new method to predict likely resistance paths to cancer treatments

Yale School of Public Health researchers have developed a new method to predict likely resistance paths to cancer therapeutics, and a methodology to apply it to one of the most frequent cancer-causing genes.

Study sheds light on common psychosocial barriers affecting HPV vaccination in Puerto Rico

Young Puerto Rican women and their mothers know little about the human papillomavirus (HPV) and cervical cancer, according to researchers at The University of Texas Health Science Center at Houston School of Public Health.

Immune-boosting drug: A new way for improving cancer treatment

Stimulating the body's own immune system to fight cancer offers new treatment opportunities for cancer patients, and scientists have made the first step towards finding existing drugs that could help.

Read more Medical News

› Verified 3 days ago